US Patent Issued to Cytodigm on March 24 for "Pharmaceutical composition of Siglec-binding agents" (Massachusetts Inventors)

ALEXANDRIA, Va., March 24 -- United States Patent no. 12,582,612, issued on March 24, was assigned to Cytodigm Inc. (Natick, Mass.).

"Pharmaceutical composition of Siglec-binding agents" was invented by Bin Wu (Lexington, Mass.), Zimeng Wang (Framingham, Mass.), Nicholas Boylan (Boylston, Mass.) and Jieni Xu (Quincy, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "This invention provides a pharmaceutical composition comprising an agent that can bind Siglec receptors on cell surface. This invention also provides the method of preparing said pharmaceutical composition and the use thereof."

The patent was filed on Oct. 5, 2021, under Application No. 17/494,555.

*For further information, including images,...